Pfizer: Sales decline hurts revenue

Comment on this story

PFIZER, the drugmaker that failed in a bid to buy UK-based AstraZeneca earlier this year, saw second-quarter revenue fall as sales of its drugs decreased, the company said yesterday. Excluding certain items, Pfizer’s earnings were 58c a share, 1c above the average estimates of 15 analysts surveyed by Bloomberg. Sales fell 2 percent to $12.8 billion (R136bn), more than analyst estimates of $12.5bn. Sales of Viagra, the erectile dysfunction pill, fell 11 percent to $427 million, including a 28 percent decline outside the US. Pfizer’s net income was $2.91bn, or 45c a share, down from $14.1bn, or $1.98 a share a year before, when Pfizer divested an animal health unit and received a legal settlement. – Bloomberg

sign up

Comment Guidelines

  1. Please read our comment guidelines.
  2. Login and register, if you haven’ t already.
  3. Write your comment in the block below and click (Post As)
  4. Has a comment offended you? Hover your mouse over the comment and wait until a small triangle appears on the right-hand side. Click triangle () and select "Flag as inappropriate". Our moderators will take action if need be.

  5. Verified email addresses: All users on Independent Media news sites are now required to have a verified email address before being allowed to comment on articles. You are only required to verify your email address once to have full access to commenting on articles. For more information please read our comment guidelines